These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32512484)

  • 41. Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227].
    Chen KF; Tai WT; Hsu CY; Huang JW; Liu CY; Chen PJ; Kim I; Shiau CW
    Eur J Med Chem; 2018 Jan; 143():2015. PubMed ID: 29113744
    [No Abstract]   [Full Text] [Related]  

  • 42. Corrigendum to "6-Amino-2,4,5-trimethylpyridin-3-ols: A new general synthetic route and antiangiogenic activity" [Eur. J. Med. Chem. 74 (2014) 126-139].
    Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
    Eur J Med Chem; 2017 Dec; 141():734-735. PubMed ID: 28988929
    [No Abstract]   [Full Text] [Related]  

  • 43. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
    [No Abstract]   [Full Text] [Related]  

  • 44. Corrigendum to "Search for new multi-target compounds against Alzheimer's disease among histamine H
    Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
    Eur J Med Chem; 2020 Nov; 205():112611. PubMed ID: 32791398
    [No Abstract]   [Full Text] [Related]  

  • 45. Corrigendum to "Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents" [Eur. J. Med. Chem. 152 (2018) 148-159].
    Ghoshal A; Kumar A; Yugandhar D; Sona C; Kuriakose S; Nagesh K; Rashid M; Singh SK; Wahajuddin M; Yadav PN; Srivastava AK
    Eur J Med Chem; 2018 Aug; 156():628-630. PubMed ID: 30031973
    [No Abstract]   [Full Text] [Related]  

  • 46. Corrigendum to "Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates" [Eur. J. Med. Chem. 134(2017) 133-139].
    Tian Z; Si L; Meng K; Zhou X; Zhang Y; Zhou D; Xiao S
    Eur J Med Chem; 2021 Nov; 223():113647. PubMed ID: 34153573
    [No Abstract]   [Full Text] [Related]  

  • 47. Corrigendum to 'Design, synthesis and in vitro study of densely functionalized oxindoles as potent α-glucosidase inhibitors' [Bioorg. Med. Chem. 26(18) (2018) 4996-5005].
    Luthra T; Naga Lalitha K; Agarwal R; Uma A; Sen S
    Bioorg Med Chem; 2018 Dec; 26(23-24):6153. PubMed ID: 30470596
    [No Abstract]   [Full Text] [Related]  

  • 48. Retraction notice to "Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors" [Eur. J. Med. Chem. (2010) 909-914].
    Eur J Med Chem; 2011 Oct; 46(10):5225. PubMed ID: 22049548
    [No Abstract]   [Full Text] [Related]  

  • 49. Retraction notice to “Synthesis and biological screening of some novel amidocarbamate derivatives of ketoprofen” [Eur. J. Med. Chem. (2010) 3162-3168].
    Eur J Med Chem; 2012 Jan; 47(1):626. PubMed ID: 22355807
    [No Abstract]   [Full Text] [Related]  

  • 50. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
    Lin CM; Kang GJ; Roach MC; Jiang JB; Hesson DP; Luduena RF; Hamel E
    Mol Pharmacol; 1991 Nov; 40(5):827-32. PubMed ID: 1944246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retraction notice to "Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors" [Eur. J. Med. Chem. 92 (2015) 459-470].
    Gomha SM; Abdulla MM; Abou-Seri SM
    Eur J Med Chem; 2016 Oct; 121():939. PubMed ID: 27523643
    [No Abstract]   [Full Text] [Related]  

  • 52. Erratum to "Synthesis of functionalized new conjugates of batracylin with tuftsin/retro-tuftsin derivatives and their biological evaluation" [Eur. J. Med. Chem. 106 (2015) 85-94].
    Januchta W; Serocki M; Dzierzbicka K; Cholewiński G; Skladanowski A
    Eur J Med Chem; 2016 Jun; 116():318-319. PubMed ID: 27177783
    [No Abstract]   [Full Text] [Related]  

  • 53. Corrigendum to: Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. Eur J Intern Med. 2019 Jan;59:65-69.
    Falhammar H; Lindh JD; Calissendorff J; Skov J; Nathanson D; Mannheimer B
    Eur J Intern Med; 2021 Sep; 91():107-108. PubMed ID: 34175185
    [No Abstract]   [Full Text] [Related]  

  • 54. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504
    [No Abstract]   [Full Text] [Related]  

  • 55. Corrigendum to "Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors" [Bioorg. Med. Chem. 25 (2017) 5077-5083].
    Innocenti R; Lenci E; Menchi G; Pupi A; Trabocchi A
    Bioorg Med Chem; 2017 Dec; 25(24):6724-6725. PubMed ID: 29111366
    [No Abstract]   [Full Text] [Related]  

  • 56. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Jan; 28(2):115255. PubMed ID: 31862309
    [No Abstract]   [Full Text] [Related]  

  • 57. Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
    Tawfik HO; El-Moselhy TF; El-Din NS; El-Hamamsy MH
    Bioorg Med Chem; 2020 Oct; 28(19):115687. PubMed ID: 32826133
    [No Abstract]   [Full Text] [Related]  

  • 58. Corrigendum to "Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors" [Bioorg. Med. Chem. 27 (2019) 115147].
    Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
    Bioorg Med Chem; 2020 Feb; 28(4):115293. PubMed ID: 31892438
    [No Abstract]   [Full Text] [Related]  

  • 59. Corrigendum to "Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR" [Bioorg. Med. Chem. 23, 2015, 2767-2780].
    Basu D; Richters A; Rauh D
    Bioorg Med Chem; 2015 Aug; 23(15):5075. PubMed ID: 32689707
    [No Abstract]   [Full Text] [Related]  

  • 60. Corrigendum to "Design and synthesis of novel thiadiazole-thiazolone hybrids as potential inhibitors of the human mitotic kinesin Eg5 [Bioorg Med Chem Lett 28 (17) (2018) 2930-2938]".
    Khathi SP; Chandrasekaran B; Karunanidhi S; Tham CL; Kozielski F; Sayyad N; Karpoormath R
    Bioorg Med Chem Lett; 2018 Nov; 28(21):3489. PubMed ID: 30279037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.